Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States

Desmond Curran, Brandon J. Patterson, Lijoy Varghese, +6

Vaccine

Impact of Routine Childhood Immunization in Reducing Vaccine-Preventable Diseases in the United States

Sandra E. Talbird, Justin Carrico, Elizabeth M. La, +5

PEDIATRICS

Impact of population aging on the burden of vaccine-preventable diseases among older adults in the United States

Sandra E. Talbird, Elizabeth M. La, Justin Carrico, +4

Human Vaccines & Immunotherapeutics

Vaccine-preventable DiseasesAgingComputational EpidemiologyFlu VaccinationVaccine Hesitancy +19

The Annual Economic Burden of Respiratory Syncytial Virus in Adults in the United States

Justin Carrico, Katherine A. Hicks, Eleanor Wilson, +2

The Journal of Infectious Diseases

Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live

Desmond Curran, Brandon J. Patterson, Desirée Van Oorschot, +5

Human Vaccines & Immunotherapeutics

Zoster Economic AnalysisVaccine HesitancyZoster VaccineUnited StatesZoster Vaccine Live +16

Optimal Allocation of Societal HIV Prevention Resources to Reduce HIV Incidence in the United States

Stephanie L. Sansom, Katherine A. Hicks, Justin Carrico, +4

American Journal of Public Health

Value of the Immunization Program for Children in the 2017 US Birth Cohort

Justin Carrico, Elizabeth M. La, Sandra E. Talbird, +6

PEDIATRICS

Cost-benefit analysis of vaccination against four preventable diseases in older adults: Impact of an aging population

Justin Carrico, Sandra E. Talbird, Elizabeth M. La, +4

Vaccine

An Open-Label, Phase I, Dose-Escalation Study of Tumor Necrosis Factor-α (TNFerade™ Biologic) Gene Transfer with Radiation Therapy for Locally Advanced, Recurrent, or Metastatic Solid Tumors

Anand Sharma, Sridhar Mani, Nader Hanna, +15

Human Gene Therapy

Radiation MedicineRadiation TherapyMedicinePathologyTnferade™ Biologic +5

Constrained Optimization for the Selection of Influenza Vaccines to Maximize the Population Benefit: A Demonstration Project

Baudouin Standaert, Ilse Van Vlaenderen, Laure-Anne Van Bellinghen, +4

Applied Health Economics and Health Policy